Another Update on Medical Abortion Litigation
Drug & Device Law
SEPTEMBER 11, 2023
FDA litigation, back in April, the United States Supreme Court had just stayed what we described as “a truly ridiculous decision purporting to invalidate a number of actions taken by FDA with regard to mifepristone, the only currently marketed approved medication for medical abortion.” 341 (2001), is so important. FDA , 727 F.
Let's personalize your content